International Journal on Magnetic Particle Imaging IJMPI
Vol. 12 No. 1 Suppl 1 (2026): Int J Mag Part Imag
https://doi.org/10.18416/IJMPI.2026.2603024

Proceedings Articles, ID 989

Enhanced brain retention time of MPI tracer via antibody conjugation

Main Article Content

Sébastien Bär (Section for Neuroelectronic Systems, Department of Neurosurgery, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg), Oliver Buchholz (Bruker BioSpin GmbH & Co. KG, Ettlingen, Germany), Christian Münkel (Neuroelectronic Systems, Department of Neurosurgery, Medical Center University of Freiburg, Medical Faculty, University of Freiburg, Freiburg, Germany), Jochen Franke (Bruker BioSpin GmbH & Co. KG, Ettlingen, Germany), Ulrich G. Hofmann (Neuroelectronic Systems, Department of Neurosurgery, Medical Center University of Freiburg, Medical Faculty, University of Freiburg, Freiburg, Germany)

Abstract

Hyperthermia guided by Magnetic Particle Imaging (MPI) is an emerging technique for targeted thermal therapies, including blood–brain barrier opening and localized tumor ablation. However, this technique works best for locally injected magnetic nanoparticles, but faces limitations with intravenous administration. Floating with circulation, the tracers often traverse the target region too quickly, succumbing to heat loss by blood cooling, thus failing to achieve sufficient localized thermal doses. This limitation reduces the efficacy of MPI-guided hyperthermia for precision applications in sensitive tissues such as the brain. Here, we propose a strategy to immobilize the magnetic nanoparticles at the brain capillary level via antibody conjugation specific to the vascular endothelium allowing future localized heating experiments. We present initial experimental proof showing the feasibility of this approach by increasing retention times of particles in the brain evidenced by extended local blood half-life.

Article Details

References

[1] Buchholz O, et al., In situ theranostic platform combining highly localized magnetic fluid hyperthermia, magnetic particle imaging, and thermometry in 3D. Theranostics 2024; 14(1):324-340. doi:10.7150/thno.86759. https://www.thno.org/v14p0324.htm
[2] Hasan M, et al., Antibody-Conjugated Magnetic Nanoparticle Therapy for Inhibiting T-Cell Mediated Inflammation. Adv Sci (Weinh). 2024 Mar;11(11):e2307148. doi: 10.1002/advs.202307148. Epub 2023 Dec 31. PMID: 38161230; PMCID: PMC10953552.

Most read articles by the same author(s)

<< < 1 2 3 > >>